Cite
HARVARD Citation
Pastore, M. et al. (2022). Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register. European Heart Journal Open. 2 (1), p. . [Online].